As mentioned earlier, the neuroprotective RAS pathway, regulated by angiotensin-converting enzyme 2 (ACE2) which converts angiotensin II into angiotensin-(1–7), can decrease both hypertension and dementia risk (Tran et al., 2022). The gene discussed is ACE2; the disease is hypertensive disorder.